4.3 Article

SARS-CoV-2 infection among healthcare workers whom already received booster vaccination during epidemic outbreak of omicron variant in Taiwan

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Immunogenicity and safety of third-dose mRNA COVID-19 vaccines in healthy adults previously vaccinated with two doses of the ChAdOx1 vaccine

Wang-Huei Sheng et al.

Summary: The study investigated the immunogenicity and adverse events of the third dose of mRNA vaccines in healthy adults. The results showed that the third dose mRNA COVID-19 vaccines markedly enhanced cellular and humoral responses and were safe. Immunological responses and adverse events were higher in individuals receiving the full-dose mRNA-1273 vaccine compared to other groups.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2023)

Letter Immunology

Increased immune escape of the new SARS-CoV-2 variant of concern Omicron

Jie Hu et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2022)

Letter Medicine, General & Internal

Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose

Constanze Kuhlmann et al.

LANCET (2022)

Article Medicine, General & Internal

Prospective health surveillance for COVID-19 among health care workers at a university medical center in Taiwan, January to June 2020

Sung-Ching Pan et al.

Summary: This article describes a prospective health surveillance of HCP and COVID-19 containment measures in a teaching hospital in Taiwan, successfully preventing COVID-19 infections.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2022)

Article Medicine, General & Internal

Original Article Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination

Wang-Huei Sheng et al.

Summary: This study investigated the efficacy and safety of heterologous prime-boost vaccination with ChAdOx1 and mRNA-1273 vaccines. The results showed that the heterologous vaccination provided higher immunogenicity compared to the homologous ChAdOx1 vaccination, and it was comparable to the homologous mRNA-1273 vaccination. Most adverse events were mild and transient. Heterologous boosting at 8 weeks resulted in fewer adverse events.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2022)

Article Medicine, General & Internal

Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study

Cristina Menni et al.

Summary: This study investigated the differences in symptom prevalence, risk of hospital admission, and symptom duration between omicron and delta variants of the SARS-CoV-2 virus. The study found that loss of smell was less common in omicron infections, sore throat was more common, and the rate of hospital admission was lower.

LANCET (2022)

Article Virology

Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults

Sneh Lata Gupta et al.

Summary: Less is known about the vaccine-induced antibody responses to variants including Omicron in children. The protection of the BNT162b2 vaccine against the Omicron variant may be insufficient. Adolescents and adults have similar antibody responses against VOCs, but exhibit a significant reduction of binding and neutralization against the Omicron variant.

JOURNAL OF VIROLOGY (2022)

Review Infectious Diseases

SARS-CoV-2 mRNA Vaccine Breakthrough Infections in Fully Vaccinated Healthcare Personnel: A Systematic Review

Caterina Ledda et al.

Summary: A systematic literature review found a very low incidence of post-vaccination breakthrough infections among healthcare personnel, which further supports the high effectiveness of mRNA vaccines in preventing COVID-19 infections. Additional studies are needed to determine the duration of vaccine-induced protection in healthcare personnel.

TROPICAL MEDICINE AND INFECTIOUS DISEASE (2022)

Review Public, Environmental & Occupational Health

COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes

Sergio Alejandro Gomez-Ochoa et al.

Summary: Health-care workers have an 11% prevalence of SARS-CoV-2 infection, with nurses being the most affected personnel, mainly working in hospital nonemergency wards. 40% of HCWs infected with COVID-19 were asymptomatic at the time of diagnosis, while 5% developed severe complications and 0.5% died.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2021)

Article Microbiology

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

Allison J. Greaney et al.

Summary: Antibodies targeting the SARS-CoV-2 spike receptor-binding domain (RBD) are key in neutralizing antibody responses, and a deep mutational scanning method was used to assess the impact of all amino-acid mutations in the RBD on antibody binding with 10 human monoclonal antibodies. The study identified the clustered escape mutations in different surfaces of the RBD that correspond to structurally defined antibody epitopes, showing that even antibodies targeting the same surface can have distinct escape mutations.

CELL HOST & MICROBE (2021)

Article Medicine, General & Internal

Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large US Health Care System

Julia M. Baker et al.

Summary: Identifying occupational and community risk factors for SARS-CoV-2 seropositivity among health care workers, the study found that community contact with COVID-19-positive individuals, community COVID-19 incidence, and being Black were significantly associated with increased odds of infection among HCWs.

ANNALS OF INTERNAL MEDICINE (2021)

Editorial Material Medicine, General & Internal

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic

Salim S. Abdool Karim et al.

LANCET (2021)

Article Medicine, General & Internal

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

Noam Barda et al.

Summary: A study using data from Israel's largest health-care organization showed that a third dose of the BNT162b2 mRNA vaccine is effective in preventing individuals from severe COVID-19-related outcomes, compared to receiving only two doses at least 5 months ago. The effectiveness of the third dose in preventing hospital admission was 93%, severe disease 92%, and COVID-19-related death 81%.

LANCET (2021)

Article Medicine, General & Internal

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

Einav G. Levin et al.

Summary: A study in Israel revealed that waning immunity after receiving two doses of the BNT162b2 vaccine led to an increase in the incidence of SARS-CoV-2 infection. Levels of spike-binding IgG and neutralizing antibodies decreased more significantly in men, individuals aged 65 or older, and immunosuppressed individuals in a longitudinal study involving nearly 4000 healthcare workers.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Public, Environmental & Occupational Health

Review Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis

P. Galanis et al.

Summary: The seroprevalence of SARS-CoV-2 antibodies among HCWs is relatively high and influenced by factors such as gender, race, work environment, and protective measures.

JOURNAL OF HOSPITAL INFECTION (2021)

Article Multidisciplinary Sciences

Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India

Mahesh S. Dhar et al.

Summary: Delhi experienced multiple severe outbreaks in 2020, reaching a seropositivity rate of >50% by 2021. The Delta variant's high transmissibility and immune evasion led to a surge in cases in Delhi.

SCIENCE (2021)

Article Medicine, General & Internal

Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel

Jesse T. Jacob et al.

Summary: The study found that healthcare personnel in three states in the USA were primarily influenced by community contact when it came to contracting the coronavirus, with workplace-related factors not showing a significant association. This indicates that current infection prevention practices in diverse healthcare settings are effective in preventing the transmission of SARS-CoV-2 from patients to healthcare personnel.

JAMA NETWORK OPEN (2021)

Article Biochemistry & Molecular Biology

Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom

Emma Pritchard et al.

Summary: Results from the Office for National Statistics COVID-19 Infection Survey in the UK demonstrate that the ChAdOx1 nCoV-19 and BNT162b2 vaccines reduce the incidence of new SARS-CoV-2 infections by up to 65% with a single dose and up to 80% after two doses, with no significant differences in efficacy observed between the two vaccines.

NATURE MEDICINE (2021)

Article Medicine, General & Internal

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

Moriah Bergwerk et al.

Summary: Among fully vaccinated health care workers, breakthrough infections with SARS-CoV-2 were correlated with neutralizing antibody titers during the peri-infection period. Most breakthrough infections were mild or asymptomatic, although persistent symptoms did occur.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Multidisciplinary Sciences

Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis

Pratha Sah et al.

Summary: Quantification of asymptomatic infections is crucial for effective public health responses to the COVID-19 pandemic. Analyzing over 350 studies, it was estimated that 35.1% of infections never developed clinical symptoms and were truly asymptomatic. At the time of testing, 42.8% of cases showed no symptoms, including both asymptomatic and presymptomatic infections.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Infectious Diseases

COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study

Reina S. Sikkema et al.

LANCET INFECTIOUS DISEASES (2020)

Article Public, Environmental & Occupational Health

Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network-13 Academic Medical Centers, April-June 2020

Wesley H. Self et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)